Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial

Iranian Journal of Medical Sciences

Volumn 38, Issue 1, 2013, Pages 38-43

  Mazloom, Zohreh ^a   Yousefinejad, Abbas ^b   Dabbaghmanesh, Mohammad Hossein ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CRP; Diabetes; Insulin resistance; Probiotic

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM STEARATE; MALONALDEHYDE; PLACEBO; PROBIOTIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG MECHANISM; EVENING DOSAGE; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

EID: 84995268070     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53. doi: 10.2337/diacare.27.5.1047. PubMed PMID: 15111519.
2. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49:571-6. PubMed PMID: 18695867
3. Voulgari C, Tentolouris N, Papadogiannis D, Moyssakis I, Perrea D, Kyriaki D, et al. Increased left ventricular arrhythmogenicity in metabolic syndrome and relationship with myocardial performance, risk factors for atherosclerosis, and low-grade inflammation. Metabolism. 2010;59:159-65. doi: 10.1016/j. metabol.2009.06.028. PubMed PMID: 19766273.
4. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev. 2006; 2:195-211. doi: 10.2174/157339906776818532. PubMed PMID: 18220627.
5. Diabetes and Aging. Diabetes Dateline [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. Inc; c2002 [cited 2007 May 14]. Available from: http://diabetes.niddk.nih.gov/about/dateline/spri02/8.html
6. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40:1286-92. doi: 10.1007/s001250050822. PubMed PMID: 9389420
7. Voulgari Ch, Tentolouris N, Moyssakis I, Dilaveris P, Gialafos E, Papadogiannis D, et al. Spatial QRS-T angle: association with diabetes and left ventricular performance. Eur J Clin Invest. 2006;36:608-13. doi:10.1111/j.1365-2362.2006.01697.x. PubMed PMID: 16919042.
8. Pasupathi P, Chandrasekar V, Kumar US. Evaluation of oxidative stress, enzymatic and non-enzymatic antioxidants and metabolic thyroid hormone status in patients with diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2009;3:160-5. doi: 10.1016/j.dsx.2009.07.004.
9. FAO/WHO [Internet]. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Inc; c2001 [cited 2007 May 14]. Available from: www.who.int/foodsafety/publications/fs/en/probiotics.pdf
10. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem. 2003;67:1421-4. doi: 10.1271/bbb.67.1421. PubMed PMID: 12843677.
11. Ali AA, Velasquez MT, Hansen CT, Mohamed AI, Bhathena SJ. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem. 2004;15:583-90. doi: 10.1016/j.jnutbio.2004.04.005. PubMed PMID: 15542349.
12. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia. 2005;48:1565-75. doi: 10.1007/s00125-005-1831-2. PubMed PMID: 15986236.
13. Fabian E, Elmadfa I. Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann Nutr Metab. 2006;50:387-93. doi: 10.1159/000094304. PubMed PMID: 16816529.
14. Søndergaard D, Meyer O, Würtzen G. Magnesium stearate given perorally to rats. A short term study. Toxicology. 1980;17:51-5. PubMed PMID: 7434368.
15. U.S. Food and Drug Administration [Internet]. USA: National Archives and Records Administration's Electronic. Code of Federal Regulations. Inc; c2002 [cited 2002, Oct 22]; [21CFR184.1440]. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=184.1440
16. Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. 2012;2012:902917. doi: 10.1155/2012/902917. PubMed PMID: 22611376; PubMed Central PMCID: PMC3352670.
17. Mann GV, Spoerry A. Studies of a surfactant and cholesterolemia in the Maasai. Am J Clin Nutr. 1974;27:464-9.
18. Yun SI, Park HO, Kang JH. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol. 2009;107:1681-6. doi: 10.1111/j.1365-2672.2009.04350.x. PubMed PMID: 19457033.
19. Gilliland SE, Walker DK. Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J Dairy Sci. 1990;73:905-11. doi: 10.3168/jds.S0022-0302(90)78747-4. PubMed PMID: 2111831
20. Gilliland SE, Nelson CR, Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol. 1985;49:377-81. PubMed PMID: 3920964; PubMed Central PMCID: PMC238411
21. Yadav H, Jain S, Sinha PR. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res. 2008;75:189-95. doi: 10.1017/S0022029908003129. PubMed PMID: 18474136.
22. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition. 2007;23:62-8. doi: 10.1016/j.nut.2006.09.002. PubMed PMID: 17084593.
23. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15:316-28. doi: 10.1016/j.numecd.2005.05.003. PubMed PMID: 16054557.
24. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012;28:539-43. doi: 10.1016/j.nut.2011.08.013. PubMed PMID: 22129852.
25. Songisepp E, Kals J, Kullisaar T, Mändar R, Hütt P, Zilmer M, et al. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J. 2005;4:22. PubMed PMID: 16080791; PubMed Central PMCID: PMC1198254.
26. Harisa GI, Taha EI, Khalil AF, Salem MM. Oral Administration of Lactobacillus Acidophilus Restores Nitric Oxide Level in Diabetic Rats. Aust J Basic and Appl Sci. 2009;3:2963-9
27. Lin MY, Chang FJ. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci. 2000;45:1617-22. PubMed PMID: 11007114.
28. Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy. 2008;38:611-8. doi: 10.1111/j.1365-2222.2008.02942.x. PubMed PMID: 18266878.
29. Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol. 2003;32:211-5. doi: 10.1080/03009740310003695. PubMed PMID: 14626627.